The clinical challenge of accurate headache diagnosis in the office can be overcome by taking a broad view of the various diagnostic categories of headache.
For many migraine sufferers, current strategies to treat headaches, or to prevent their occurrence, are insufficient to ward off the near-daily occurrence of head pain, prompting researchers to investigate methods of pre-emptive migraine treatment.
Teasing out relevant the relationship among risk factors, comorbidities, and migraine is challenging but critical for optimal migraine treatment.
Among multiple sclerosis (MS) patients, a combination of estriol and Copaxone (glatiramer acetate) reduced the rate of relapse by 50% percent within one year of treatment.
An intranasal midazolam spray designed to treat seizures in epilepsy patients yielded favorable results in an early trial.